TMCI Stock Analysis: Buy, Sell, or Hold?
TMCI - Treace Medical Concepts, Inc. Common Stock
$2.32
0.02 (0.87%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When TMCI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TMCI is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TMCI is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TMCI is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.42 to $2.78.
Technical Outlook: Technically, TMCI is in a strong downtrend. The price is currently testing key support at $2.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TMCI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.87 (+109.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TMCI is in a strong downtrend. The price is currently testing key support at $2.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TMCI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.87 (+109.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.42 -
$2.78
Company Quality Score
45/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 109.9% below Wall St target ($4.87)
- WARNING: Recommendation downgraded due to -10.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.42 -
$2.78
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.31
(13.3%)
Support & Resistance Levels
Support Level
$2.27
Resistance Level
$2.75
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.41
Wall Street Target
$4.87
(+109.9%)
Revenue Growth (YoY)
11.4%
Profit Margin
-22.9%
Last updated: February 01, 2026 5:19 PM ET
Data refreshes hourly during market hours. Next update: 6:19 PM
Data refreshes hourly during market hours. Next update: 6:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMCI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
